472 related articles for article (PubMed ID: 22878663)
1. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis.
Kobayashi Z; Tsuchiya K; Arai T; Aoki M; Hasegawa M; Ishizu H; Akiyama H; Mizusawa H
J Neurol Sci; 2010 Jun; 293(1-2):6-11. PubMed ID: 20409561
[TBL] [Abstract][Full Text] [Related]
3. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation.
Tateishi T; Hokonohara T; Yamasaki R; Miura S; Kikuchi H; Iwaki A; Tashiro H; Furuya H; Nagara Y; Ohyagi Y; Nukina N; Iwaki T; Fukumaki Y; Kira J
Acta Neuropathol; 2010 Mar; 119(3):355-64. PubMed ID: 19967541
[TBL] [Abstract][Full Text] [Related]
4. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
5. [Amyotrophic lateral sclerosis (ALS) with the mutations in the fused in sarcoma/translocated in liposarcoma gene].
Aoki M
Rinsho Shinkeigaku; 2013; 53(11):1080-3. PubMed ID: 24291885
[TBL] [Abstract][Full Text] [Related]
6. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
[TBL] [Abstract][Full Text] [Related]
7. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.
Mackenzie IR; Ansorge O; Strong M; Bilbao J; Zinman L; Ang LC; Baker M; Stewart H; Eisen A; Rademakers R; Neumann M
Acta Neuropathol; 2011 Jul; 122(1):87-98. PubMed ID: 21604077
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
[TBL] [Abstract][Full Text] [Related]
9. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.
Nishihira Y; Tan CF; Onodera O; Toyoshima Y; Yamada M; Morita T; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2008 Aug; 116(2):169-82. PubMed ID: 18481073
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological characteristics of FUS/TLS-associated amyotrophic lateral sclerosis (ALS)].
Murayama S
Rinsho Shinkeigaku; 2010 Nov; 50(11):948-50. PubMed ID: 21921522
[TBL] [Abstract][Full Text] [Related]
11. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
Lashley T; Rohrer JD; Bandopadhyay R; Fry C; Ahmed Z; Isaacs AM; Brelstaff JH; Borroni B; Warren JD; Troakes C; King A; Al-Saraj S; Newcombe J; Quinn N; Ostergaard K; Schrøder HD; Bojsen-Møller M; Braendgaard H; Fox NC; Rossor MN; Lees AJ; Holton JL; Revesz T
Brain; 2011 Sep; 134(Pt 9):2548-64. PubMed ID: 21752791
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
14. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
[TBL] [Abstract][Full Text] [Related]
15. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
[TBL] [Abstract][Full Text] [Related]
16. FUS pathology in basophilic inclusion body disease.
Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
[TBL] [Abstract][Full Text] [Related]
17. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.
Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
Acta Neuropathol; 2011 Feb; 121(2):219-28. PubMed ID: 20886222
[TBL] [Abstract][Full Text] [Related]
18. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
19. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions.
Huang EJ; Zhang J; Geser F; Trojanowski JQ; Strober JB; Dickson DW; Brown RH; Shapiro BE; Lomen-Hoerth C
Brain Pathol; 2010 Nov; 20(6):1069-76. PubMed ID: 20579074
[TBL] [Abstract][Full Text] [Related]
20. A Japanese ALS6 family with mutation R521C in the FUS/TLS gene: a clinical, pathological and genetic report.
Yamamoto-Watanabe Y; Watanabe M; Okamoto K; Fujita Y; Jackson M; Ikeda M; Nakazato Y; Ikeda Y; Matsubara E; Kawarabayashi T; Shoji M
J Neurol Sci; 2010 Sep; 296(1-2):59-63. PubMed ID: 20621307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
